Engineered Intracellular Nanobody Blocks Active Opioid Receptors to Modulate Neural Circuits
Researchers have engineered an intracellular nanobody inhibitor that selectively binds active opioid receptors, suppressing transducer coupling and attenuating opioid-driven dopamine ...

